Dr. Rajha Vijay Kumar
Bangalore, Dec 11: A team of researchers headed by Dr. Rajha Vijay Kumar in Bangalore has developed a revolutionary non-invasive method for treating osteoarthritis and cancer.
Using the technique, the Dr. Kumar said 36 patients with severe osteoarthritis were treated successfully. “They are without pain now, can walk normally and climb stairs without help,” he said.
Similarly, an end-stage lung cancer patient was also subjected to the treatment and the results were “miraculous” – the 43-year-old Hyderabad-based branch manager of National Insurance Company P Ravikumar “is now symptom-free and has resumed his duties”, he said.
The technique, Rotational Field Quantum Magnetic Resonance (RFQMR) generator, said to be the first in the world, has been developed by the team from the Institute of Aerospace Medicine, IAF, in Bangalore, and the Centre for Advanced Research and Development (CARD) after seven years of research.
The team comprised of Dr Rajah Vijay Kumar, director of CARD and the inventor of the RFQMR technology, Wing Commander V G Vasishta, professor and head of the department of Radio-Diagnosis, IAM IAF, and Surgeon Commander L J Pinto, professor and head of the Department of Human Engineering, IAM IAF.
“RFQMR is a new machine for which an international patent is pending. RFQMR produces high-power multi-frequency rotating quantum electromagnetic resonating beams from 96 special RFQMR guns that are precisely focused to the target area of interest,” Kumar told me.
Dr. Kumar said RFQMR works on the principle of altering cell membrane potential and “jamming” the “command and control” of the target tissue cells, by altering the proton spin inside and outside the cells.
The project to develop the technology was initiated seven years ago.
According to Dr. Kumar, in a pilot study conducted during the last six months, 36 patients with severe osteoarthritis were exposed to RFQMR beams for one hour every day for 21 days.
All the patients had severe pain of long duration, severe limitation of movements and all conventional modalities of treatment had proved unsuccessful; the only other alternative of surgery remained, they said.
Results showed that all 36 patients showed marked subjective improvement and stopped takinng painkillers by the fourth exposure, and by the end of the treatment, almost all of them could walk for one to five km without pain and 16 of the 36 could squat on the floor, which they could not do earlier, Dr. Kumar said.
“The 30 days follow-up showed that all the 36 patients were without pain, could walk normally and could climb stairs without help.”
To understand and “prove” the efficacy of RFQMR’s degenerative properties, the team subjected for treatment Ravikumar, a patient, whose cancer had spread to the liver and kidney, and said the results were “miraculous.”
The very same team previously also invented an equipment named Hamatron, which when connected to patient via leads like in EKG, can provide physicians with information hitherto was not available regarding cardiac function. This equipment has already recieved preliminary approval from US FDA and is placed on Fast Track.
Disclaimer: I am on the advisory panel of this research with regard to treatment of brain tumors, however, I have no monetary interest nor gain.
Author: Dr. K.B. Mallya
